Evidence-Based Reviews

ADHD: Only half the diagnosis in an adult with inattention?

Author and Disclosure Information

 

References

Dr. Ghaemi receives research grants from GlaxoSmithKline and Pfizer and is a speaker for GlaxoSmithKline, AstraZeneca, Pfizer, and Abbott Laboratories. Neither he nor his family hold equity positions in pharmaceutical companies.

Pages

Recommended Reading

ALS Drug Appears to Ease Resistant Depression
MDedge Psychiatry
Research Into Seizure Prediction Devices Advances : No adverse events have been reported in the two ongoing phase III implanted device studies.
MDedge Psychiatry
White-Matter Deficit Seen in Stuttering Children
MDedge Psychiatry
Depression History a Possible Marker For Auras Following Epilepsy Surgery
MDedge Psychiatry
Art Provides Window on Epilepsy Experience
MDedge Psychiatry
Frequency, Painfulness of Restless Legs Must Guide Treatment
MDedge Psychiatry
Gene Mutation Tied to 5% of Frontotemporal Dementia
MDedge Psychiatry
How dopamine drives cocaine craving
MDedge Psychiatry
Make ADHD treatment as effective as possible
MDedge Psychiatry
Do neural disconnects cause schizophrenia?
MDedge Psychiatry